HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman.

AuthorsFrancesco Passamonti, Elisa Rumi, Lucia Malabarba, Luca Arcaini, Ester Orlandi, Ercole Brusamolino, Cristiana Pascutto, Mario Cazzola, Mario Lazzarino
JournalAnnals of hematology (Ann Hematol) Vol. 83 Issue 8 Pg. 495-7 (Aug 2004) ISSN: 0939-5555 [Print] Germany
PMID15175894 (Publication Type: Journal Article)
Chemical References
  • Pipobroman
Topics
  • Adult
  • Cause of Death
  • Drug Evaluation
  • Female
  • Humans
  • Incidence
  • Leukemia (etiology, prevention & control)
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Pipobroman (administration & dosage)
  • Remission Induction
  • Survival Analysis
  • Thrombocythemia, Essential (complications, drug therapy, mortality)
  • Thrombosis (etiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: